Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 147

Results For "Inc"

5697 News Found

Coveris invests over €8 million in production capacity
Packaging | May 14, 2024

Coveris invests over €8 million in production capacity

Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany


Zydus receives final approval from USFDA for Dexamethasone Tablets
Drug Approval | May 13, 2024

Zydus receives final approval from USFDA for Dexamethasone Tablets

Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)


Briefs: Lupin and Aurobindo Pharma
News | May 13, 2024

Briefs: Lupin and Aurobindo Pharma

Lupin updates on shipment of Mirabegron ER Tablets


Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr
News | May 12, 2024

Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr

Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024


OMRON Healthcare India and AliveCor partner to improve heart healthcare in India
Healthcare | May 11, 2024

OMRON Healthcare India and AliveCor partner to improve heart healthcare in India

These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more


Ami Organics posts Q4 FY24 consolidated profit at Rs. 25.14 Cr
News | May 11, 2024

Ami Organics posts Q4 FY24 consolidated profit at Rs. 25.14 Cr

Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024


Piramal Pharma posts Q1 FY24 consolidated PAT at Rs. 101.27 Cr
News | May 11, 2024

Piramal Pharma posts Q1 FY24 consolidated PAT at Rs. 101.27 Cr

Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024


Neuland Laboratories posts Q4 FY24 consolidated PAT at Rs. 67.56 Cr
News | May 11, 2024

Neuland Laboratories posts Q4 FY24 consolidated PAT at Rs. 67.56 Cr

Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024


Cipla posts Q4 FY24 consolidated PAT at Rs. 939.04 Cr
News | May 11, 2024

Cipla posts Q4 FY24 consolidated PAT at Rs. 939.04 Cr

The company has posted net profit of Rs. 4,121.55 crores for the Financial Year ended March 31, 2024


Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr
News | May 11, 2024

Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr

The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024